⌘K

Home/Filings/4/0000899243-21-005337

4//SEC Filing

Crowley John J 4

Accession 0000899243-21-005337

CIK 0001805890other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 9:27 PM ET

Size

9.9 KB

Accession

0000899243-21-005337

Insider Transaction Report

Form 4

Period: 2021-02-04

Fusion Pharmaceuticals Inc.FUSN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-02-04+138,000→ 138,000 total
Exercise: $11.90Exp: 2031-02-03→ Common Stock (138,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to this option shall vest and become exercisable on February 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Documents

2 files

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1

filerCIK 0001587972

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 9:27 PM ET
Size: 9.9 KB

View on SEC.gov